Available
24/7
Call or text us
757.622.5000
(757) 622-5000

The FDA has requested the removal of all Ranitidine (Zantac) products from the market. Studies have indicated that the widely popular heartburn medication may contain unacceptable levels of a dangerous carcinogen, N-Nitrosodimethylamine (NDMA.) Tests conducted by the analytical pharmacy Valisure found “extremely high levels of N-Nitrososdimethylamine in every lot” of ranitidine tested, including those produced by different manufacturers such as Sanofi US, Pfizer, GlaxoSmithKline, and Boehringer Ingelheim Pharmaceuticals, among others.

Zantac Users May be at Higher Risk for Certain Cancers

While additional research is needed to determine the cancer risks posed by Zantac, the medical community concurs that prolonged use of higher doses of ranitidine means more exposure to this dangerous carcinogen. There are many types of cancers associated with ranitidine exposure, including:

  • Breast Cancer
  • Esophageal Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Thyroid Cancer
  • Testicular Cancer
  • Stomach/Gastric Cancer
  • Colon Cancer
  • Large Intestine Cancer
  • Small Intestine Cancer
  • Rectal Cancer

Legal Allegations Against Makers of Zantac

These serious side effects have spawned a wave of lawsuits, in which plaintiffs argue that Zantac manufacturers failed to warn consumers about the risks of NDMA.

Zantac lawsuits cite earlier studies, some dating back more than 30 years, which show that drug makers were aware that ranitidine was unstable and could transform into NDMA in various conditions within the human body. After taking Zantac for heartburn, one plaintiff, who developed bladder cancer, claims that manufacturers were more concerned about profits than public safety and deliberately concealed their knowledge about high levels of NDMA.

Since the FDA recall, the number of Zantac lawsuits has increased substantially in courtrooms across the nation. On August 26, the honorable Robin Rosenberg was appointed by the Judicial Counsel on Multidistrict Litigation to oversee the Zantac Multidistrict litigation (MDL 2924) in the Southern District of Florida. 

Do You Qualify to File a Zantac Lawsuit?

To file a Zantac lawsuit, claimants must be able to show that they took ranitidine for at least 12 months, were diagnosed with a serious illness, and were not sufficiently warned of all potential side effects. If you took Zantac or another product containing ranitidine and were diagnosed with cancer, it’s best to speak with an experienced lawyer at Rutter Mills about your legal options.

There are strict time limits for taking legal action, so do not delay. Contact Rutter Mills to discuss your case. Reach out anytime, 24/7, for a free consultation with a caring and qualified member of our team.